Literature DB >> 17988975

[The coverage of cervical screening in Hungary].

Imre Boncz1, Andor Sebestyén, Lajos Döbrossy, Attila Kovács, András Budai, Tamás Székely.   

Abstract

UNLABELLED: The purpose of this study is to calculate the proportion of women having cytological examination (Pap smear) of cervix either within or outside of the Hungarian organized cervical cancer screening programme.
METHODS: The data derive from the financial database of the National Health Insurance Fund Administration (OEP) of Hungary covering the period of 2000-2005. The period 2000-2002 was considered as a reference period of opportunistic screening, while 2003-2005 was the first screening circle of organized screening.
RESULTS: Between 2000-2002 1 667 618 women underwent cytological examination of Pap smear, and it increased to 1 749 498 women between 2003-2005. In the age-group 25-64 years, the annual coverage varied between 22.0-23.3% in 2000-2002, and it increased to 23.4-24.3% between 2003-2005. In the target population the 3-years-coverage increased from 48.9% in 2000-2002 to 52.6% in 2003-2005 (+3.7%).
CONCLUSIONS: The organized screening programme managed to increase moderately the coverage of target population. In order to realize the mortality decline due to cervical cancer, participation rate must be increased.

Entities:  

Mesh:

Year:  2007        PMID: 17988975     DOI: 10.1556/OH.2007.28956

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  4 in total

1.  Young Hungarian Students' Knowledge about HPV and Their Attitude Toward HPV Vaccination.

Authors:  Bettina Claudia Balla; András Terebessy; Emese Tóth; Péter Balázs
Journal:  Vaccines (Basel)       Date:  2016-12-29

2.  Predicting cervical screening and HPV vaccination attendance of Roma women in Hungary: community nurse contribution is key.

Authors:  Annamária Pakai; Réka Mihály-Vajda; Zsuzsanna Kívés Horváthné; Krisztina Szabó Gabara; Eszter Basa Bogdánné; András Oláh; Miklós Zrínyi; Adrienn Siket Újváriné
Journal:  BMC Nurs       Date:  2022-01-30

3.  Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary.

Authors:  Zoltán Vokó; László Nagyjánosi; Zoltán Kaló
Journal:  BMC Public Health       Date:  2012-10-30       Impact factor: 3.295

4.  General practitioners can increase participation in cervical cancer screening - a model program in Hungary.

Authors:  Anikó Gyulai; Attila Nagy; Vera Pataki; Dóra Tonté; Róza Ádány; Zoltán Vokó
Journal:  BMC Fam Pract       Date:  2018-05-19       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.